Related Articles
Decreased expression of circulating microRNA-126 in patients with type 2 diabetic nephropathy: A potential blood-based biomarker
Diabetic neuropathy: A narrative review of risk factors, classification, screening and current pathogenic treatment options (Review)
Associations between apolipoprotein CIII concentrations and microalbuminuria in type 2 diabetes
MicroRNA‑499a (rs3746444A/G) gene variant and susceptibility to type 2 diabetes‑associated end‑stage renal disease
miR‑199a‑3p is involved in the pathogenesis and progression of diabetic neuropathy through downregulation of SerpinE2